STOCK TITAN

Thoughtful Brands Inc. Engages Electrik Dojo for Native Advertising and Digital Marketing

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Thoughtful Brands Inc. (OTCQB: PEMTF) has engaged Electrik Dojo for a two-month period to enhance its brand awareness through native advertising and digital marketing. The engagement will cost the Company USD $300,000 and includes investor relations activities. Thoughtful Brands operates in the natural health products sector and has a significant presence in the CBD market and psychedelic medicine. It also runs a 110,000 square foot pharmaceutical facility in Germany focused on clinical studies involving psilocybin for opiate addiction treatment.

Positive
  • Engaged Electrik Dojo for digital marketing to boost brand awareness.
  • Strategic investment of USD $300,000 for marketing services.
  • Strong presence in the growing CBD and psychedelic medicine markets.
  • Ownership of a pharmaceutical facility in Germany for clinical studies.
Negative
  • None.

VANCOUVER, BC / ACCESSWIRE / August 28, 2020 / Thoughtful Brands Inc. (CSE:TBI)(FSE:1WZ1)(OTCQB:PEMTF) (the "Company" or "Thoughtful Brands"), a global natural health products and eCommerce technology company, is pleased to announce it has engaged Electrik Dojo for native advertising and digital marketing services to increase brand awareness for the Company. Certain services to be provided by Electrik Dojo are anticipated to include investor relations activities under the policies of the CSE and applicable securities laws. The company will continue to look at strategic consultants to expand awareness of the Company and its activities. The Company will compensate Electrik Dojo for a two-month period at a total rate of USD $300,000.

About Thoughtful Brands Inc.

Thoughtful Brands Inc. is an eCommerce technology company that researches, develops, markets, and distributes natural health products through various brands in North America and Europe. Through continuous strategic acquisitions, the Company has a strong footprint in the CBD market, as well as the burgeoning psychedelic medicine sector. Thoughtful Brands owns and operates a 110,000 square foot pharmaceutical manufacturing facility in Radebeul, Germany, where its highly skilled team conducts clinical studies utilizing naturally occurring psilocybin and other compounds found in psychedelics for the treatment of opiate addiction, while planning for future opportunities to create proprietary psilocybin products.

ON BEHALF OF THE BOARD OF DIRECTORS
THOUGHTFUL BRANDS INC.

Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at info@thoughtful-brands.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statement

All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws, including with respect to its plans to acquire additional revenue-producing natural health product brands and operations in both Europe and North America with the goal of establishing an international distribution network utilizing its eCommerce technology platform. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company's public filings under the Company's SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

SOURCE: Thoughtful Brands Inc.



View source version on accesswire.com:
https://www.accesswire.com/603904/Thoughtful-Brands-Inc-Engages-Electrik-Dojo-for-Native-Advertising-and-Digital-Marketing

FAQ

What services is Thoughtful Brands engaging Electrik Dojo for?

Thoughtful Brands is engaging Electrik Dojo for native advertising and digital marketing services to enhance brand awareness.

How much is Thoughtful Brands paying Electrik Dojo?

Thoughtful Brands will compensate Electrik Dojo USD $300,000 for a two-month engagement.

What markets does Thoughtful Brands operate in?

Thoughtful Brands operates in the natural health products sector, with a focus on the CBD and psychedelic medicine markets.

Where is Thoughtful Brands' pharmaceutical facility located?

Thoughtful Brands operates a pharmaceutical facility in Radebeul, Germany.

What clinical studies is Thoughtful Brands conducting?

Thoughtful Brands conducts clinical studies utilizing psilocybin for the treatment of opiate addiction.

THOUGHFUL BRANDS INC NEW

OTC:PEMTF

PEMTF Rankings

PEMTF Latest News

PEMTF Stock Data

24
37.21M
0.07%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Vancouver